NCT02792023

Brief Summary

Prospective study to test whether the immunochemical fecal occult blood test (FIT) for colorectal cancer (CRC) helps to prioritize patients with iron deficiency anemia for colonoscopy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
550

participants targeted

Target at P50-P75 for not_applicable colorectal-cancer

Timeline
Completed

Started Jun 2016

Typical duration for not_applicable colorectal-cancer

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 20, 2016

Completed
18 days until next milestone

First Posted

Study publicly available on registry

June 7, 2016

Completed
23 days until next milestone

Study Start

First participant enrolled

June 30, 2016

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2019

Completed
Last Updated

February 19, 2019

Status Verified

February 1, 2019

Enrollment Period

3.1 years

First QC Date

May 20, 2016

Last Update Submit

February 17, 2019

Conditions

Keywords

Colorectal cancerImmunochemical occult blood test

Outcome Measures

Primary Outcomes (1)

  • The number of patients with colorectal cancer among those with a positive immunochemical fecal test (Positive predictive value)

    In order to calculate the positive predictive value, the number of patients with events (colorectal cancers) will be divided among the number of positive immunochemical fecal tests

    one year

Secondary Outcomes (2)

  • The number of patients with a significant lesion among those with a positive immunochemical fecal test (Positive predictive value) after the colonoscopy and after the upper endoscopy

    one year

  • The number of patients without a significant lesion among those with a negative immunochemical fecal test (negative predictive value) after the colonoscopy and after the upper endoscopy

    one year

Study Arms (2)

Colonoscopy followed by upper endoscopy

OTHER

In case of a positive immunochemical fecal occult blood test result, colonoscopy will be the first examination

Other: Immunochemical fecal occult blood testDevice: ColonoscopyDevice: Upper endoscopy

Upper endoscopy followed by colonoscopy

OTHER

In case of a negative immunochemical fecal occult blood test result, upper endoscopy will be the first examination

Other: Immunochemical fecal occult blood testDevice: ColonoscopyDevice: Upper endoscopy

Interventions

Participants will be provided with a single immunochemical fecal occult blood test. Participants will introduce a small sample of feces inside and bring the test to the hospital

Colonoscopy followed by upper endoscopyUpper endoscopy followed by colonoscopy

A colonoscopy (procedure performed using a scope design to examine the large bowel) will be offered to the participants

Colonoscopy followed by upper endoscopyUpper endoscopy followed by colonoscopy

An upper endoscopy (procedure performed using a scope to examine the upper digestive tract) will be offered to the participants

Colonoscopy followed by upper endoscopyUpper endoscopy followed by colonoscopy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Consecutive outpatients with iron deficiency anemia (Hemoglobin \< 13 g/dl in males and 12 g/dl in females) referred for upper endoscopy and/or colonoscopy.
  • To sign the informed consent.

You may not qualify if:

  • \< 18 years
  • Pregnancy
  • Personal history of inflammatory bowel disease
  • Gastric / duodenal ulcer or gastrointestinal neoplasia
  • Family history of hereditary CRC (Lynch Syndrome or familial adenomatous polyposis)
  • Rectal bleeding / hematochezia
  • Gastroscopy / colonoscopy / endoscopy capsule in the previous 5 years
  • Patients not candidates for endoscopic studies because a low performance status
  • Previous abdominal surgery
  • Refusal to participate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Digestive Service, Huc

San Cristóbal de La Laguna, S/C de Tenerife, 38320, Spain

RECRUITING

Related Publications (6)

  • James MW, Chen CM, Goddard WP, Scott BB, Goddard AF. Risk factors for gastrointestinal malignancy in patients with iron-deficiency anaemia. Eur J Gastroenterol Hepatol. 2005 Nov;17(11):1197-203. doi: 10.1097/00042737-200511000-00008.

    PMID: 16215432BACKGROUND
  • Hamilton W, Lancashire R, Sharp D, Peters TJ, Cheng KK, Marshall T. The importance of anaemia in diagnosing colorectal cancer: a case-control study using electronic primary care records. Br J Cancer. 2008 Jan 29;98(2):323-7. doi: 10.1038/sj.bjc.6604165. Epub 2008 Jan 22.

    PMID: 18219289BACKGROUND
  • Quintero E, Castells A, Bujanda L, Cubiella J, Salas D, Lanas A, Andreu M, Carballo F, Morillas JD, Hernandez C, Jover R, Montalvo I, Arenas J, Laredo E, Hernandez V, Iglesias F, Cid E, Zubizarreta R, Sala T, Ponce M, Andres M, Teruel G, Peris A, Roncales MP, Polo-Tomas M, Bessa X, Ferrer-Armengou O, Grau J, Serradesanferm A, Ono A, Cruzado J, Perez-Riquelme F, Alonso-Abreu I, de la Vega-Prieto M, Reyes-Melian JM, Cacho G, Diaz-Tasende J, Herreros-de-Tejada A, Poves C, Santander C, Gonzalez-Navarro A; COLONPREV Study Investigators. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med. 2012 Feb 23;366(8):697-706. doi: 10.1056/NEJMoa1108895.

    PMID: 22356323BACKGROUND
  • Quintero E, Carrillo M, Gimeno-Garcia AZ, Hernandez-Guerra M, Nicolas-Perez D, Alonso-Abreu I, Diez-Fuentes ML, Abraira V. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening. Gastroenterology. 2014 Nov;147(5):1021-30.e1; quiz e16-7. doi: 10.1053/j.gastro.2014.08.004. Epub 2014 Aug 13.

    PMID: 25127679BACKGROUND
  • Rodriguez-Alonso L, Rodriguez-Moranta F, Ruiz-Cerulla A, Lobaton T, Arajol C, Binefa G, Moreno V, Guardiola J. An urgent referral strategy for symptomatic patients with suspected colorectal cancer based on a quantitative immunochemical faecal occult blood test. Dig Liver Dis. 2015 Sep;47(9):797-804. doi: 10.1016/j.dld.2015.05.004. Epub 2015 May 15.

    PMID: 26055489BACKGROUND
  • Cubiella J, Salve M, Diaz-Ondina M, Vega P, Alves MT, Iglesias F, Sanchez E, Macia P, Blanco I, Bujanda L, Fernandez-Seara J. Diagnostic accuracy of the faecal immunochemical test for colorectal cancer in symptomatic patients: comparison with NICE and SIGN referral criteria. Colorectal Dis. 2014 Aug;16(8):O273-82. doi: 10.1111/codi.12569.

    PMID: 24456168BACKGROUND

MeSH Terms

Conditions

Colorectal Neoplasms

Interventions

ColonoscopyGastroscopy

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Intervention Hierarchy (Ancestors)

Endoscopy, GastrointestinalEndoscopy, Digestive SystemDiagnostic Techniques, Digestive SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Officials

  • Enrique Quintero, MD, PhD

    Hospital Universitario de Canarias

    STUDY DIRECTOR

Central Study Contacts

Marta Carrillo, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 20, 2016

First Posted

June 7, 2016

Study Start

June 30, 2016

Primary Completion

August 1, 2019

Study Completion

October 1, 2019

Last Updated

February 19, 2019

Record last verified: 2019-02

Locations